Insights On Outsourced Drug Development

  1. Precision Medicine: Going Digital To Drive Innovation 6/2/2023

    The Precision Medicine Initiative is driving forward the potential for a more customized health care approach, transforming the way health care professionals are treating diseases.

  2. Rapid, Automated, At-Line Adenovirus Quantitation 9/27/2024

    Gain insight into how a high-throughput capsid assay for rapid AV quantification was developed using an innovative Bio-Layer Interferometry (BLI) platform that offers high precision and reliability.

  3. Microglia: Where We Came From And Where We Are Now 10/8/2024

    Gain expert insights into the evolution of microglia research and the future of this field, including the innovative tools being developed to investigate the role of microglia in health and disease.

  4. Lightning-Link® Conjugation Kits: Consistent Performance On A Broad Scale 9/26/2024

    Learn about labeling technology offering a transformative solution through direct antibody labeling without the need for post-conjugation purification, thereby mitigating antibody loss and ensuring reproducible results.

  5. Rapid Delivery Of Toxicological Study Material: Accelerating Development 3/19/2025

    Explore key strategies and technologies designed to address the analytical considerations and material flows to facilitate the rapid delivery of toxicological material.

  6. The Technology Debate: Single-Use vs. Stainless Steel 10/4/2023

    In this discussion you will explore the multi-point case for adopting single-use technologies throughout the workflow via an economic, operational, and environmental sustainability lens.

  7. Key Factors To Consider When Selecting A Stereo Microscope 1/8/2024

    Utilize this comprehensive guide to choose the right stereo microscope for your application, and learn about the key factors you should consider and analyze.

  8. A Pre-Clinical Study For Diet-Induced Obesity 3/28/2025

    Here, we look at the importance of using high-fat diet-induced obesity models to evaluate and compare the efficacy of anti-obesity and anti-diabetic treatments like rimonabant and liraglutide.

  9. Therapeutic Effects Of An ALK5 Inhibitor In Preclinical Fibrosis Models 3/28/2025

    Our preclinical studies evaluating ALK5 inhibition in various mouse models of fibrosis have demonstrated differing degrees of therapeutic benefit, suggesting the potential for selective targeting.

  10. Surface Plasmon Resonance for Biomolecular Interaction Analysis 4/15/2025

    Explore how uncovering molecular interactions can drive breakthroughs in disease understanding, drug discovery, and therapeutic innovation.